Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Reducing Postherpetic Neuralgia
Galveston, Texas - A recent analysis of data from an ongoing open-label trial provides strong validation of an earlier finding that adjunctive treatment of acute herpes zoster using the anticonvulsant drug gabapentin (Neurontin) dramatically reduces the incidence of postherpetic neuralgia, Mathijs H. Brentjens, M.D.
Related Videos
Related Content
Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD
October 1st 2023
Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD
October 1st 2023
